605 related articles for article (PubMed ID: 17918265)
1. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
Dzhala VI; Brumback AC; Staley KJ
Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
[TBL] [Abstract][Full Text] [Related]
2. NKCC1 transporter facilitates seizures in the developing brain.
Dzhala VI; Talos DM; Sdrulla DA; Brumback AC; Mathews GC; Benke TA; Delpire E; Jensen FE; Staley KJ
Nat Med; 2005 Nov; 11(11):1205-13. PubMed ID: 16227993
[TBL] [Abstract][Full Text] [Related]
3. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic efficacy of bumetanide in an in vitro model of posttraumatic epileptogenesis.
Dzhala V; Staley KJ
CNS Neurosci Ther; 2015 Feb; 21(2):173-80. PubMed ID: 25495911
[TBL] [Abstract][Full Text] [Related]
5. NKCC1 activity modulates formation of functional inhibitory synapses in cultured neocortical neurons.
Nakanishi K; Yamada J; Takayama C; Oohira A; Fukuda A
Synapse; 2007 Mar; 61(3):138-49. PubMed ID: 17146765
[TBL] [Abstract][Full Text] [Related]
6. Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus.
Nardou R; Ben-Ari Y; Khalilov I
J Neurophysiol; 2009 Jun; 101(6):2878-88. PubMed ID: 19297515
[TBL] [Abstract][Full Text] [Related]
7. Sustained depolarizing shift of the GABA reversal potential by glutamate receptor activation in hippocampal neurons.
Kitamura A; Ishibashi H; Watanabe M; Takatsuru Y; Brodwick M; Nabekura J
Neurosci Res; 2008 Dec; 62(4):270-7. PubMed ID: 18840481
[TBL] [Abstract][Full Text] [Related]
8. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1.
Kahle KT; Barnett SM; Sassower KC; Staley KJ
J Child Neurol; 2009 May; 24(5):572-6. PubMed ID: 19406757
[TBL] [Abstract][Full Text] [Related]
9. Depolarizing shift in the GABA-induced current reversal potential by lidocaine hydrochloride.
Nakahata Y; Miyamoto A; Watanabe M; Moorhouse AJ; Nabekura J; Ishibashi H
Brain Res; 2010 Jul; 1345():19-27. PubMed ID: 20580693
[TBL] [Abstract][Full Text] [Related]
10. Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus.
Barmashenko G; Hefft S; Aertsen A; Kirschstein T; Köhling R
Epilepsia; 2011 Sep; 52(9):1570-8. PubMed ID: 21899534
[TBL] [Abstract][Full Text] [Related]
11. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
[TBL] [Abstract][Full Text] [Related]
12. Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.
Palma E; Amici M; Sobrero F; Spinelli G; Di Angelantonio S; Ragozzino D; Mascia A; Scoppetta C; Esposito V; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 2006 May; 103(22):8465-8. PubMed ID: 16709666
[TBL] [Abstract][Full Text] [Related]
13. Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse.
Kilb W; Sinning A; Luhmann HJ
Neuropharmacology; 2007 Sep; 53(4):524-33. PubMed ID: 17681355
[TBL] [Abstract][Full Text] [Related]
14. Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures.
Glykys J; Dzhala VI; Kuchibhotla KV; Feng G; Kuner T; Augustine G; Bacskai BJ; Staley KJ
Neuron; 2009 Sep; 63(5):657-72. PubMed ID: 19755108
[TBL] [Abstract][Full Text] [Related]
15. Coincident pre- and postsynaptic activity downregulates NKCC1 to hyperpolarize E(Cl) during development.
Balena T; Woodin MA
Eur J Neurosci; 2008 May; 27(9):2402-12. PubMed ID: 18430034
[TBL] [Abstract][Full Text] [Related]
16. Distinct types of ionic modulation of GABA actions in pyramidal cells and interneurons during electrical induction of hippocampal seizure-like network activity.
Fujiwara-Tsukamoto Y; Isomura Y; Imanishi M; Fukai T; Takada M
Eur J Neurosci; 2007 May; 25(9):2713-25. PubMed ID: 17459104
[TBL] [Abstract][Full Text] [Related]
17. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures.
Cleary RT; Sun H; Huynh T; Manning SM; Li Y; Rotenberg A; Talos DM; Kahle KT; Jackson M; Rakhade SN; Berry G; Jensen FE
PLoS One; 2013; 8(3):e57148. PubMed ID: 23536761
[TBL] [Abstract][Full Text] [Related]
18. Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital.
Nardou R; Yamamoto S; Chazal G; Bhar A; Ferrand N; Dulac O; Ben-Ari Y; Khalilov I
Brain; 2011 Apr; 134(Pt 4):987-1002. PubMed ID: 21436113
[TBL] [Abstract][Full Text] [Related]
19. Shunting and hyperpolarizing GABAergic inhibition in the high-potassium model of ictogenesis in the developing rat hippocampus.
Isaev D; Isaeva E; Khazipov R; Holmes GL
Hippocampus; 2007; 17(3):210-9. PubMed ID: 17294460
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome.
Tyzio R; Khalilov I; Represa A; Crepel V; Zilberter Y; Rheims S; Aniksztejn L; Cossart R; Nardou R; Mukhtarov M; Minlebaev M; Epsztein J; Milh M; Becq H; Jorquera I; Bulteau C; Fohlen M; Oliver V; Dulac O; Dorfmüller G; Delalande O; Ben-Ari Y; Khazipov R
Ann Neurol; 2009 Aug; 66(2):209-18. PubMed ID: 19743469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
